New Rochelle Kids Dental Dentist - Pediatric Dentistry Medicare: Not Enrolled in Medicare Practice Location: 77 Quaker Ridge Rd, Suite 210, New Rochelle, NY 10804 Phone: 914-632-2800 Fax: 914-560-2075 |
Robert F. Perler, Dds,ms,llc Dentist Medicare: Medicare Enrolled Practice Location: 175 Memorial Hwy, Suite 1-6, New Rochelle, NY 10801 Phone: 914-636-8082 |
New Rochelle Oral Surgery Dentist - Oral and Maxillofacial Surgery Medicare: Not Enrolled in Medicare Practice Location: 77 Quaker Ridge Rd, Suite 212, New Rochelle, NY 10804 Phone: 914-235-1235 Fax: 914-235-0794 |
Greg Seinfeld Dds Clinic/Center - Dental Medicare: Not Enrolled in Medicare Practice Location: 77 Quaker Ridge Rd Ste 201, New Rochelle, NY 10804 Phone: 914-636-0032 |
Jennifer Pichardo Dds Pc Dentist - General Practice Medicare: Not Enrolled in Medicare Practice Location: 140 Lockwood Ave, Suite 215, New Rochelle, NY 10801 Phone: 914-235-7453 Fax: 914-813-0381 |
New Rochelle Dental Arts Dentist - General Practice Medicare: Not Enrolled in Medicare Practice Location: 466 Main St Ste 101, New Rochelle, NY 10801 Phone: 914-633-5050 |
Joseph A.tamagna Dds Pc Dentist - Oral and Maxillofacial Surgery Medicare: Not Enrolled in Medicare Practice Location: 421 Huguenot St, Suite 11, New Rochelle, NY 10801 Phone: 914-235-9316 Fax: 914-235-9316 |
News Archive
While obesity significantly increases your chances of developing heart failure, for those with established heart failure it may confer a survival benefit compared with normal weight or underweight individuals, a new paper by researchers from the University of Adelaide reports.
Although predominantly a respiratory illness, emerging data suggests that multi-organ injury is common, particularly in moderate to severe infections. A new study published on the preprint server medRxiv* in October 2020 describes the illness's sequelae in the months after recovery.
Omeros Corporation, a biopharmaceutical company committed to discovering, developing and commercializing small-molecule and protein therapeutics for both large-market as well as orphan indications targeting inflammation, coagulopathies and disorders of the central nervous system, today announced that the European Medicines Agency's (EMA's) Committee for Medicinal Products for Human Use (CHMP) has adopted a positive opinion for Omidria® (phenylephrine and ketorolac injection) 1%/0.3%.
Scientists conducted a cohort study and measured the prevalence and the levels of antibody responses to the nucleocapsid protein of SARS-CoV-2 and four seasonal human coronaviruses.
› Verified 5 days ago